NCT00288730View on ClinicalTrials.gov

A Study of Two Doses of Intravenous NATRECOR hBNP (Nesiritide) in Patients With Worsening Congestive Heart Failure Who Have Difficulty Breathing at Rest

PHASE3CompletedINTERVENTIONAL

Enrollment

127

Participants

Timeline

Start Date

October 31, 1996

Study Completion Date

August 31, 1997

Conditions

Heart Failure, CongestiveHeart Decompensation

Interventions

DRUG

nesiritide

All Listed Sponsors

lead

Scios, Inc.

INDUSTRY